ZACKSยท2025-10-28 14:41Core Insights - HCA Healthcare is currently outperforming its peers in the Medical sector with a year-to-date return of 55.9%, significantly higher than the sector average of 2.6% [4] - The Zacks Rank for HCA Healthcare is 2 (Buy), indicating a positive earnings outlook and strong analyst sentiment, with a 2.7% increase in the consensus estimate for full-year earnings over the past 90 days [3][4] - HCA Healthcare belongs to the Medical Services industry, which has seen an average gain of 7% this year, further highlighting its strong performance relative to the industry [6] Company Performance - HCA Healthcare's year-to-date return is 55.9%, showcasing its strong market performance compared to the Medical sector's average return of 2.6% [4] - The Zacks Consensus Estimate for HCA's full-year earnings has improved by 2.7% over the last 90 days, reflecting a positive shift in analyst sentiment [4] - HCA Healthcare holds a Zacks Rank of 2 (Buy), indicating favorable conditions for potential investors [3] Industry Context - HCA Healthcare is part of the Medical Services industry, which consists of 63 individual stocks and currently ranks 92 in the Zacks Industry Rank [6] - The Medical Services industry has gained an average of 7% year-to-date, positioning HCA Healthcare as a strong performer within this segment [6] - In comparison, Acadia Pharmaceuticals, another stock in the Medical sector, has a year-to-date return of 25.3% and belongs to the Medical - Biomedical and Genetics industry, which has increased by 10.3% this year [5][6]